Guillain-Barré syndrome have been Describe as a condition in which the immune system attacks the nerves.
The condition may be triggered by an acute bacterial or viral infection
The United State Has record 20,000 cases per year infected by Guillain-Barré syndrome
Guillain-Barré syndrome Full Definition
Guillain–Barré syndrome Shortly Spelled and Known as (GBS) is a quick-onset muscle weakness which is caused by the immune system damaging the peripheral nervous system, Typically both sides of the body are involved, and the initial symptoms are changes in sensation or pain often in the back along with muscle weakness, beginning in the feet and hands, often spreading to the arms and the upper body.
The symptoms might establish over hours to a few weeks, During the acute phase, the disorder can be life-threatening, with about 15% of people experiencing weakness of the breathing muscles and, therefore, requiring mechanical ventilation (artificial ventilation).
Some are affected by changes in the function of the autonomic nervous system, which can also lead to dangerous abnormalities in heart rate and blood pressure.
What Are The Causes Of Guillain-Barré syndrome
The actual cause of Guillain-Barre syndrome haven’t been fully known yet. but The Disorder usually appears days or weeks after a breathing or digestive tract infection. Rarely, recent surgery or vaccination can bring about Guillain-Barre syndrome.
There have been cases newly reported following infection with the Zika virus. Guillain-Barre syndrome may also occur after infection with the COVID-19.
List Of Viriuses/Diseases or Infection That Can Lead To Guillain-Barré syndrome
- Hepatitis A, B, C and E
- HIV, the virus that causes AIDS
- Mycoplasma pneumonia
- Hodgkin’s lymphoma
- Rarely, influenza vaccinations or childhood vaccinations
- Most commonly, infection with campylobacter, a type of bacteria often found in undercooked poultry
- Influenza virus
- Epstein-Barr virus
- Zika virus
Symptoms and Sign Of Guillain-Barré syndrome
- Pain areas in the muscles
- muscle weakness
- abnormality walking
- problems with coordination
- weaknessof the arms and legs
- Whole body: fatigue or high blood pressure
- Heart: abnormal heart rhythm or fast heart rate
- difficulty speaking
- difficulty swallowing
- facial muscle weakness
- shortness of breath
- slow reflexes
- uncomfortable tingling and burning
- urinary retention
- difficulty raising the foot
Complications Of Guillain-Barré syndrome
Nerves is the major part Guillain-Barre syndrome Affect, Because nerves control your movements and body functions, people with Guillain-Barre may experience
- Heart and blood pressure problems: Blood pressure fluctuations(changes) and irregular heart rhythms (cardiac arrhythmias) are commonly side effects of Guillain-Barre syndrome.
- Pain: some people with Guillain-Barre syndrome undergo severe nerve pain, which may be relieve with medication.
- Relapse: up to 2% to 5% of people with Guillain-Barre syndrome encounter a relapse.
- Breathing disturbance: The weakness or paralysis can spread to the muscles that establish your breathing, a potentially fatal complication. Up to 22% of those with Guillain-Barre syndrome need short-term help from a machine to breathe within the first week when they’re hospitalized for Medication or treatment.
- Residual insensibility or other sensations: Most people with Guillain-Barre syndrome recover completely or have only minor, residual weakness, numbness or tingling.
- Blood clots: Those who are motionless due to Guillain-Barre syndrome are at high risk of developing blood clots. Until you’re able to walk independently, taking blood thinners and wearing support stockings may be recommended.
- Bowel and bladder function problems: Slow bowel function and urine detention may result from Guillain-Barre syndrome.
How To Prevent Guillain-Barre syndrome
As Doctors and Scientists have not yet determined how to prevent Guillain-Barré syndrome, Doctors has also Advise individuals to prevent having the disease and Viriuses That lead to Guillain-Barre syndrome which is listed earlier on this article, including
Most commonly infection with campylobacter, a type of bacteria often found in undercooked poultry, Influenza virus, Cytomegalovirus, Epstein-Barr virus, Zika virus, Hepatitis A, B, C and E, HIV, the virus that causes AIDS, Mycoplasma pneumonia, Surgery, Trauma, Hodgkin’s lymphoma
Rarely, influenza vaccinations or childhood vaccinations, COVID-19 and more
Since Guillain-Barré syndrome is not a disease itself, and it is not fully known exactly how it occurs, it is hard to say how GBS could be prevented. Scientists are already putting on finding new treatments and refining the existing ones. Scientists are also looking at the workings of the immune system to find which cells are responsible for beginning and carrying out the attack on the nervous system.
The truth that so many cases of Guillain-Barré syndrome begin after a viral or bacterial infection suggests that certain characteristics of some viruses and bacteria may activate the immune system inappropriately. Investigators are searching for those characteristics.
Guillain-Barre syndrome Cure And Treatment
Guillain-Barre syndrome Treatment consists of transfusions
Special blood treatments (plasma exchange and immunoglobulin therapy) can relieve symptoms. Physical therapy is needed.
Ways on how to Cure and Treat Guillain-Barre syndrome
- Medications: Blood transfusion
- Supportive care,: Mechanical ventilation and Intubation
- Therapies: Physical therapy
Transfer of blood from one person into the veins of another.
Mechanical ventilation: Using a machine to move air in and out of the lungs when a person cannot breathe on their own.
Intubation: Inserting a tube into the lungs to protect or open the airway.
Physical therapy: Restores muscle strength and function through exercise.
Immunotherapy: Plasmapheresis and intravenous immunoglobulins (IVIG) are the two main immunotherapy treatments for Guillain-Barre syndrome (GBS), Plasmapheresis make a efforts to reduce the body’s attack on the nervous system by filtering antibodies out of the bloodstream. Similarly, administration of IVIG neutralizes harmful antibodies and inflammation.
These two part of treatments are equally effective, but a combination of the two is not remarkably better than either alone.
Plasmapheresis makes the recovery quick when used within four weeks of the onset of symptoms.
IVIG works as well as plasmapheresis when started within two weeks of the onset of symptoms, and has fewer complications.
IVIG is usually used first because of its ease of administration and safety. Its use is not without risk; occasionally it causes liver inflammation, or in rare cases, kidney failure.
Glucocorticoids alone have not been found to be effective in speeding recovery and could potentially delay recovery.
Guillain-Barré syndrome History
Georges Guillain, Barré and Strohl, described two cases of self-limiting acute paralysis with Strange changes in the cerebrospinal fluid.
He succeeded his teacher Pierre Marie as professor of neurology at the Salpêtrière hospital in Paris in 1925.
Jean-Baptiste Octave Landry first described the disorder in 1859. In 1916, Georges Guillain, Jean Alexandre Barré, and André Strohl diagnosed two soldiers with the illness and report the key diagnostic abnormality—albuminocytological dissociation—of increased spinal fluid protein concentration but a normal cell count.
C. Miller Fisher described the variant that bears his name in 1956, British neurologist Edwin Bickerstaff point the encephalitis type in 1951 and made further contributions with another paper in 1957. Guillain had reported on some of these features before their full description in 1938.
Additionally subtypes have been described since then, such as the form featuring pure ataxia and the type causing pharyngeal-cervical-brachial weakness, The axonal subtype was first described in the year 1986.
Diagnostic standard were developed in the late 1970s after the series of cases associated with swine flu vaccination. These were refined in 1990. The case explanation was revised by the Brighton Collaboration for vaccine safety in 2009, but is mainly calculated for research.
Plasma exchange was first used in 1978, and its benefit was confirmed in larger studies in 1985.
Thanks For Reading this so far, and I hope you would have understand the meaning of Guillain-Barré syndrome, please kindly share this to social media platforms, as this is really helpful, and don’t forget to always visit Daveplay Homepage for more info’s